These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 2667032
1. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology]. Semmler W, Gückel F, Bachert-Baumann P, Lorenz WJ, van Kaick G. Radiologe; 1989 Jul; 29(7):330-5. PubMed ID: 2667032 [Abstract] [Full Text] [Related]
2. Magnetic resonance spectroscopy applied to clinical oncology. Leach MO. Technol Health Care; 1994 Dec; 2(4):235-46. PubMed ID: 7842308 [Abstract] [Full Text] [Related]
3. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy. van Laarhoven HW, Punt CJ, Kamm YJ, Heerschap A. Crit Rev Oncol Hematol; 2005 Dec; 56(3):321-43. PubMed ID: 15982898 [Abstract] [Full Text] [Related]
4. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA. Clin Cancer Res; 2005 May 01; 11(9):3503-13. PubMed ID: 15867253 [Abstract] [Full Text] [Related]
5. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX. Chin Med J (Engl); 2009 Jan 05; 122(1):39-43. PubMed ID: 19187615 [Abstract] [Full Text] [Related]
11. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ, Li CW, Chuang HY, Liu GC, Wang CK. J Comput Assist Tomogr; 2008 Mar 05; 32(6):987-94. PubMed ID: 19204465 [Abstract] [Full Text] [Related]
12. 31P-magnetic resonance spectra of ovarian cancer cells exposed to chemotherapy within a three-dimensional Matrigel construct. Abramov Y, Carmi S, Cohen JS, Anteby SO, Ringel I. Oncol Rep; 2012 Aug 05; 28(2):735-41. PubMed ID: 22581188 [Abstract] [Full Text] [Related]
15. High resolution nuclear magnetic resonance spectroscopy in clinical biology: application in oncology. de Certaines JD. Anticancer Res; 1996 Aug 05; 16(3B):1325-31. PubMed ID: 8694498 [Abstract] [Full Text] [Related]
16. Observation of intramyocellular lipids by 1H-magnetic resonance spectroscopy. Boesch C, Kreis R. Ann N Y Acad Sci; 2000 May 05; 904():25-31. PubMed ID: 10865706 [Abstract] [Full Text] [Related]
17. In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models. Le Moyec L, Naruse S, Higuchi T, Hirakawa K, Watari H, de Certaines JD, Roques BP. Cancer Biochem Biophys; 1988 Jul 05; 10(1):31-45. PubMed ID: 2465078 [Abstract] [Full Text] [Related]
18. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model. Papadopoulou MV, Pouremad R, Bloomer WD, Wyrwicz A. Anticancer Res; 2006 Jul 05; 26(5A):3259-63. PubMed ID: 17094438 [Abstract] [Full Text] [Related]
19. [Prospects for the application of 31-phosphorus NMR to the surveillance of anticancer treatment]. Le Moyec L, Benoist L, de Certaines J. Bull Cancer; 1985 Jul 05; 72(6):506-15. PubMed ID: 3912015 [Abstract] [Full Text] [Related]